Anixa Biosciences, Inc. company information, Employees & Contact Information

Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference Yahoo Finance

Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial PR Newswire

Anixa Biosciences (NASDAQ: ANIX) to present at Spartan Capital Conference in New York Stock Titan

Patent ZL2020800215666 extends breast cancer vaccine protection in China to 2040 | Anixa Biosciences Stock Titan

35 Patients Complete Breast Cancer Vaccine Trial — Anixa to Present Immune, Safety Data Dec 11 Stock Titan

Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival PR Newswire

Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial PR Newswire

Some Patients Treated in Anixa's Ovarian Cancer CER T Trial Show Longer-Than-Expected Survival CGTLive®

Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference PR Newswire

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones PR Newswire

Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s PR Newswire

28-Month Survival Milestone: Anixa's Novel Ovarian Cancer CAR-T Therapy Shows Promise in Phase 1 Trial Stock Titan

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology PR Newswire

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial PR Newswire

Cancer-focused Biotech Anixa Biosciences to Present at Major H.C. Wainwright Investment Conference in NYC Stock Titan

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines PR Newswire

Anixa Biosciences CEO Provides Letter to Shareholders PR Newswire

Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention PR Newswire

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview PR Newswire

Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology Finansavisen

Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s Finansavisen

Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference Finansavisen

Anixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology Finansavisen

Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial Finansavisen

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset PR Newswire

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting PR Newswire

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial PR Newswire

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine PR Newswire

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy PR Newswire

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial PR Newswire

Anixa Biosciences Wraps Up Dosing of Second Cohort in Ovarian Cancer CER-T Trial CGTLive®

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine PR Newswire

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board PR Newswire

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine Finansavisen

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock PR Newswire